Validation of the Labcorp Plasma Focus Test to Facilitate Precision Oncology Through Cell-Free DNA Genomic Profiling of Solid Tumors-Reference-Cited by-同舟云学术

Validation of the Labcorp Plasma Focus Test to Facilitate Precision Oncology Through Cell-Free DNA Genomic Profiling of Solid Tumors

Published:2023-07 Issue:7 Volume:25 Page:477-489
ISSN:1525-1578
Container-title:The Journal of Molecular Diagnostics
language:en
Short-container-title:The Journal of Molecular Diagnostics

Author:

Verner Ellen L.^ORCID,Jackson Jennifer B.^ORCID,Severson Eric,Valkenburg Kenneth C.^ORCID,Greer Amy E.,Riley David R.,Sausen Mark^ORCID,Maddox Cynthia,McGregor Paul M.,Karandikar Aanavi,Hastings Stephanie B.,Previs Rebecca A.^ORCID,Reddy Venkataprasanth P.^ORCID,Jensen Taylor J.,Ramkissoon Shakti H.

Publisher

Elsevier BV

Subject

Molecular Medicine,Pathology and Forensic Medicine

Reference50 articles.

1. Recommendations for a practical implementation of circulating tumor DNA mutation testing in metastatic non-small-cell lung cancer;Heitzer;ESMO Open,2022

2. Molecular profiling for precision cancer therapies;Malone;Genome Med,2020

3. The economic value of liquid biopsy for genomic profiling in advanced non-small cell lung cancer;Ezeife;Ther Adv Med Oncol,2022

4. A prospective study of circulating tumor DNA to guide matched targeted therapy in lung cancers;Sabari;J Natl Cancer Inst,2019

5. PPM2 comprehensive genomic testing in advanced non-small cell lung cancer (NSCLC): a cost-effectiveness analysis of plasma-based circulating tumor DNA (CTDNA) next-generation sequencing (NGS) to inform first-line treatment decisions;Lopes;Value Health,2020

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative profiling of whole-cell and exosome samples reveals protein signatures that stratify breast cancer subtypes;Cellular and Molecular Life Sciences;2024-08-22

2. The changing face of circulating tumor DNA (ctDNA) profiling: Factors that shape the landscape of methodologies, technologies, and commercialization;Medizinische Genetik;2023-11-29

3. Correction;The Journal of Molecular Diagnostics;2023-11

4. Analytical validation of the PROphet test for treatment decision-making guidance in metastatic non-small cell lung cancer;2023-04-24